Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib and Gemcitabine in Relapsed/Refractory PTCL or NK/T-cell Lymphoma
NCT03052933Phase 2Completed
- Sponsor
- Chonnam National University Hospital
- Start
- Feb 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of copanlisib in peripheral T-cell lymphoma (PTCL), Natural killer T-cell lymphoma (NKTL), sponsored by Chonnam National University Hospital. Started Feb 2018; status: completed.
02
Drugs
copanlisib
03
Conditions
peripheral T-cell lymphoma (PTCL)Natural killer T-cell lymphoma (NKTL)
Beyond the preview
Go deeper on NCT03052933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03052933.